COMMUNIQUÉS West-GlobeNewswire

Crown Bioscience annonce une expansion de son site de San Diego, en Californie
10/05/2019
Création d'un Centre d'excellence international pour l'offre de services translationnels dans les domaines des inflammations et des biomarqueurs en oncologie SAN DIEGO, 10 mai 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, [...]
Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
10/05/2019
Pooled analysis published in Pain and Therapy indicated that the number of rescue medication tablets used per day through Week 24 was significantly less for ZILRETTA versus placebo and triamcinolone acetonide [...]
Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update
10/05/2019
CAMBRIDGE, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]
Acasti Settles Claims with Former Chief Executive Officer
10/05/2019
LAVAL, Québec, May 10, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced that it has settled regarding claims made against the Company by its former [...]
Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019
NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019
NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
10/05/2019
CANTON, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for [...]
MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million
10/05/2019
TORONTO, May 10, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation [...]
Nexstim enters depression therapy market in Sweden
10/05/2019
Press release, Helsinki, 10 May at 2.00 pm (EET) Nexstim enters depression therapy market in Sweden Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated [...]
BioCryst to Present at Bank of America Merrill Lynch Health Care Conference
10/05/2019
RESEARCH TRIANGLE PARK, N.C., May 10, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the Bank of America Merrill Lynch Health Care Conference in [...]
Nabriva Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019
DUBLIN, Ireland, May 10, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today [...]
Trevena Reports First Quarter 2019 Results
10/05/2019
— Company announces receipt of FDA feedback on healthy volunteer study protocol and analysis plan for oliceridine — – Study on track to initiate by end of June – Company to host conference call Monday, May 13, 2019 at 8 [...]
Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
10/05/2019
CRANBURY, N.J., May 10, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Bank of America [...]
ContraFect Reports First Quarter 2019 Financial Results and Provides Business Update
10/05/2019
YONKERS, N.Y., May 10, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents, comprised of lysins and [...]
Recro Pharma Reports First Quarter 2019 Financial Results
10/05/2019
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Philadelphia, May 10, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharma company with a high-performing, revenue generating contract [...]
TG Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
10/05/2019
Conference Call to be held today, Friday, May 10, 2019 at 8:00 AM ET NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ended [...]
FDA Approves Prior Approval Supplement for BIVIGAM®
10/05/2019
ADMA Announces it will Commence Commercial Sales of BIVIGAM® RAMSEY, N.J. and BOCA RATON, Fla., May 10, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated [...]
PLx Pharma Inc. Reports First Quarter 2019 Results
10/05/2019
Company submits briefing package to U.S. Food and Drug Administration HOUSTON, May 10, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company [...]
Stemline Therapeutics Reports First Quarter 2019 Financial Results
10/05/2019
Net revenue for ELZONRIS was $5.05 million for the first quarter Conference call and live webcast scheduled for today at 8:00 AM ET NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), [...]

Pages